Position in INDV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$23,693,881
+$13,863,380 QoQ
Shares Held
577,477
+79.0% QoQ
Ownership
0.489%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#46
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DANSKE BANK A/S holds $93,885,353 across 13 Drug Manufacturers - Specialty & Generic names. INDV ranks #1 (25.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
577,477 | $23,693,881 | |
| 2 | ZTS |
Zoetis Inc.
|
277,326 | $19,928,645 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
583,026 | $14,348,269 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
304,539 | $10,317,781 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
18,349 | $9,942,037 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
52,095 | $8,780,090 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
60,756 | $6,740,270 | |
| 8 | VTRS |
Viatris Inc
|
8,000 | $127,040 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,693,881 | 577,477 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $9,830,501 | 322,523 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||